Latest News Archive

Please select Category, Year, and then Month to display items

UFS implements interventions to increase diversity of researchers

03 January 2022 | Story André Damons | Photo Supplied

Seven supported academics from the Afromontane Research Unit (ARU) on the Qwaqwa Campus saw an increase in their H-indices (Google Scholar) during 2020.

Over the past few years, the university has implemented special interventions to increase the diversity of UFS researchers, including targeted appointments and focused research capacity development and support. Strategic interventions relating to National Research Foundation (NRF) rating resulted in the UFS having a well-established cohort of rated researchers.

According to the recent internal research report, the UFS has 144 researchers in the A, B and C categories (established according to NRF criteria), and 57 researchers under the age of 40 who are considered emerging researchers in the P and Y categories. This brings the total to 201 rated researchers in 2021, compared to 188 in 2020, and 164 in 2019. The university also has 57 Y-rated researchers.

Furthermore, the university submitted 51 applications to the NRF under the 2020 rating call, including 21 first-time applications (of which four were unsuccessful) and 26 who were invited to reapply to keep their ratings active (of which all were successful).

Prof Corli Witthuhn, Vice-Rector: Research and Internationalisation, says the UFS has been able to appoint outstanding young researchers over the past eight years. “Not only did these exceptional individuals contribute to our scholarship and research productivity, but they also increased our diversity. The increase in the diversity of our NRF-rated academics is an aspect of the research portfolio that I am most proud of,” says Prof Witthuhn.

Highlighted trends regarding NRF-rated researchers

• There has been a constant growth in the number of rated researchers, from 127 in 2016 to 202 in 2021.
• The majority of NRF-rated researchers (186 in 2021) are from the Bloemfontein Campus. The number of rated researchers from the Qwaqwa Campus increased from 4 in 2016 to 13 in 2021. The South Campus increased its number of rated researchers by two in 2021, with a current total of three rated researchers.
• The Faculty of Natural and Agricultural Sciences has the highest percentage of rated researchers (45%) in 2021, followed by the Faculty of the Humanities (29%).
• The percentage of rated white researchers declined from 92% in 2016 to 78% in 2021, and the rated black researchers increased from 6% in 2016 to 17% in 2021.
• The percentage of rated female researchers increased from 27% in 2016 to 34% in 2021.
• Rated researchers in the C2 and C3 rating categories declined slightly, from 52% in 2019 to 47% in 2021. There is still positive growth in the number of young (Y1/Y2) rated researchers – from 14% in 2016 to 27% in 2021.

Ratings and promotions

The university hosts a total of six South African Research Chairs (SARChI) funded by the NRF / Department of Science and Innovation (DSI), of which four are held by women. Three chairs are appointed in the Faculty of Natural and Agricultural Sciences and the Faculty of Education, while the faculties of Economic and Management Sciences and Health Sciences appointed one chair each. Two research chairs have been renewed for 2021-2025.

Seven supported academics from the Afromontane Research Unit (ARU) on the Qwaqwa Campus saw an increase in their H-indices (Google Scholar) during 2020, while one new Y1 NRF rating was awarded and another was increased to C2 level. Two ARU-supported academics achieved professorial status in the same year.

Twenty-five young academics on the cusp of NRF rating and promotion to the rank of Associate Professor are participating in the Future Professoriate Mentoring Programme, while the 25 participants of the ESAP group have completed their doctorates over the past three years and are working towards obtaining a Y-rating. As a result of the outstanding progress of the first cohort of the mentoring programme during 2020, a second cohort of ESAP scholars was selected in March 2021. More than 80% of the 75 group members are younger than 40 years.

Drs Frans Kruger and Lodewyk Sutton also received NRF Y-ratings in November 2020. The ESAP programme currently has three recipients of the FirstRand NRF Black African Advancement Fellowship Programme: Dr Eugene Baron (Practical Theology), Dr Mirriam Moleko (School of Mathematics and Science Education), and Dr Neo Pule (Psychology). Dr Lizemari Hugo from the School of Nursing also received a FAIMER (Foundation for Advancement of International Medical Education and Research) fellowship. Dr Mikateko Höppener (Centre for Development Support) has been selected to participate in the national DHET Future Professoriate Programme.

Publication output units show significant increase

The publication output units (books, conference proceedings, and journal articles) by UFS researchers, as measured and reported to the Department of Higher Education and Training (DHET), show consistent growth from 2016 to 2020. The output units increased significantly in 2019 and 2020 after a slight decrease in 2017.

There has also been a notable increase in books/chapters since 2018. Journal articles also showed constant growth from 2017 onwards, especially from 2019 to 2020, with a 20% growth in journal outputs visible; however, conference proceedings declined last year.

Main contributors

The faculties of Natural and Agricultural Sciences, the Humanities, and Theology and Religion remain the main contributors to the university’s publication output. Four faculties (Economic and Management Sciences, Education, Health Sciences, and Theology and Religion) increased their share of units in 2020 compared to the 2016-2019 period.

The journal output units generated from scholarly articles published in internationally indexed journals remained more than 80% (82% in 2017, 85% in 2018, 81% in 2019, and 85% in 2020). Only 15% of journal articles were published in South African indexed (DHET) journals (compared to 24% in 2016). Since 2016, there has been a clear shift towards publications in internationally indexed journals.

The following nine in-house journals are being administered by the UFS:

Acta Academica (editor: Henning Melber), Acta Structilia (editor: K Kajimo-Shakantu), Acta Theologica (editor: Jan-Albert van den Berg), Communitas (editor: Willemien Marais), Journal for Juridical Science (editor: Bradley Smith), Journal for Translation Studies in Africa (editor: Kobus Marais), Perspectives in Education (editor: Jan Nieuwenhuis), Southern Journal for Contemporary History (editor: Neil Roos), and Town and Regional Planning (editor: Maléne Campbell).

All are DHET-accredited, except for the Journal for Translation Studies in Africa, a new KovsieJournals title.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease

2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013

The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.

In future further evaluation will be performed in other forms of hypocholesterolemia.

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept